p53 directly transactivates Delta133p53alpha, regulating cell fate outcome in response to DNA damage.
Summary of "p53 directly transactivates Delta133p53alpha, regulating cell fate outcome in response to DNA damage."
We have previously reported that the human p53 gene encodes at least nine different p53 isoforms, including Delta133p53alpha, which can modulate p53 transcriptional activity and apoptosis. In this study, we aimed to investigate the regulation of Delta133p53alpha isoform expression and its physiological role in modulating cell cycle arrest and apoptosis. We report here that in response to a low dose of doxorubicin (which induces cell cycle arrest without promoting apoptosis), p53 directly transactivates the human p53 internal promoter, inducing Delta133p53alpha protein expression. The induced Delta133p53alpha then inhibits p53-dependent apoptosis and G1 arrest without inhibiting p53-dependent G2 arrest. Therefore, endogenous Delta133p53alpha does not exclusively function in a dominant-negative manner toward p53, but differentially regulates cell cycle arrest and apoptosis.Cell Death and Differentiation advance online publication, 6 August 2010; doi:10.1038/cdd.2010.91.
Affiliation
Centre for Oncology and Molecular Medicine, Inserm-European Associated Laboratory U858, University of Dundee, College of Medicine, Dundee, DD1 9SY, UK.
Journal Details
This article was published in the following journal.
Name: Cell death and differentiation
ISSN: 1476-5403
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20689555
- DOI: http://dx.doi.org/10.1038/cdd.2010.91
Medical and Biotech [MESH] Definitions
Bacterial Secretion Systems
Processes that translocate macromolecules across the cell envelope of gram negative bacteria, often directly into the host. These effectors modulate the defense response and thereby facilitate survival of the pathogen.
Genes, Developmental
Genes that determine the fate of a cell or CELLS in a region of the embryo during EMBRYONIC DEVELOPMENT.
Receptors, Pituitary Hormone-regulating Hormone
Cell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here.
Glucocorticoid-induced Tnfr-related Protein
A member of the TNF receptor family that was initially identified as a DEXAMETHASONE-induced protein from a T-CELL line. It may play a role in regulating APOPTOSIS and modulating immune response by T-lymphocytes. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.
Dose-response Relationship, Immunologic
A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.
PubMed Articles
p53 dynamics control cell fate.
Cells transmit information through molecular signals that often show complex dynamical patterns. The dynamic behavior of the tumor suppressor p53 varies depending on the stimulus; in response to doubl...
The RNA helicase p68 is a potent co-activator of p53-dependent transcription in response to DNA damage. Previous independent studies have indicated that p68 and the Delta133p53 isoforms, which modulat...
Ras Effector Switching Promotes Divergent Cell Fates in C. elegans Vulval Patterning.
The C. elegans vulva is patterned by epidermal growth factor (EGF) activation of Ras to control 1° fate, and 1° fate induces antagonistic Notch-dependent 2° fate. Furthermore, a spatial EGF gradien...
Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage.
Polycomb protein histone methyltransferase enhancer of Zeste homologe 2 (EZH2) is frequently overexpressed in human malignancy and is implicated in cancer cell proliferation and invasion. However, it...
Mechanical signals of both low and high intensity are inhibitory to fat and anabolic to bone in vivo, and have been shown to directly affect mesenchymal stem cell pools from which fat and bone precurs...
Clinical Trials
Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)
Squamous Cell Carcinoma (SCC) is one of the most common malignancies in caucasian population. The effect of the immune system on the development of skin tumors has been demonstrated in tra...
Magnesium Supplementation to Prevent Bone Loss
Extreme magnesium deficiency is known to have an impact on the synthesis, secretion and/or action of calcium regulating hormones. Many older adults are at risk for less severe magnesium d...
Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism
OBJECTIVES: I. Determine the prevalence of glucocorticoid-remediable aldosteronism (GRA) in various hypertensive populations and screen at risk members of GRA pedigrees. II. Investigate o...
Cell-mediated Immune Response to Influenza Vaccine
Influenza virus is an important cause of morbidity in the transplant population and can lead to viral and bacterial pneumonia. Although the annual influenza vaccine is recommended for orga...
Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
IL13-PE38QQR is an oncology drug product consisting of IL13 (interleukin-13) and PE38QQR (a bacteria toxin). IL3-PE38QQR is a protein that exhibits cell killing activity against a variety...
